⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

Official Title: An Open-Label, Multiple Simon 2-Stage Study of Itacitinib Administered Orally to Subjects With Primary Myelofibrosis (PMF), Post Polycythemia Vera Myelofibrosis (PPV-MF) or Post Essential Thrombocythemia Myelofibrosis (PET-MF)

Study ID: NCT01633372

Interventions

itacitinib

Study Description

Brief Summary: This is a study of itacitinib (INCB039110) in patients with myelofibrosis. This study will evaluate safety and efficacy parameters of itacitinib (INCB039110).

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Birmingham Hematology Oncology Associates, LLC, Birmingham, Alabama, United States

Mayo Clinic, Arizona, Scottsdale, Arizona, United States

UCLA Hematology & Oncology, Los Angeles, California, United States

Emory University, Atlanta, Georgia, United States

St Agnes Hospital, Baltimore, Maryland, United States

University of Michigan Cancer Center, Ann Arbor, Michigan, United States

Mount Sinai School of Medicine, New York, New York, United States

Oregon Health & Science University, Portland, Oregon, United States

University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States

South Carolina Oncology & Associates, Columbia, South Carolina, United States

Boston Baskin Cancer Foundation, Inc., Memphis, Tennessee, United States

Tennessee Oncology, Nashville, Tennessee, United States

MD Anderson Cancer Center, Houston, Texas, United States

St Vincent's Hospital, Darlinghurst, New South Wales, Australia

St. George Hospital, Kogarah, New South Wales, Australia

Box Hill Hospital, Box Hill, Victoria, Australia

Frankston Hospital, Frankston, Victoria, Australia

Cross Cancer Institute, Edmonton, Alberta, Canada

St. Paul's Hospital, Vancouver, British Columbia, Canada

Princess Margaret Hospital, Toronto, Ontario, Canada

St. Mary's Hospital, Montreal, Quebec, Canada

Contact Details

Name: Albert Assad, MD

Affiliation: Incyte Corporation

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: